NWP
HRTX icon

Northstar Wealth Partners’s Heron Therapeutics HRTX Stock Holding History

Northstar Wealth Partners’s Portfolio HRTX Stock Details HRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-5,315
Closed -$206K – 185
2018
Q2 		$206K Buy
+5,315
New +$169K 0.1% 177

Other funds holding HRTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

Northstar Wealth Partners's HRTX Position: Q3 2018 in Review

Northstar Wealth Partners sold out of Heron Therapeutics (HRTX) in Q3 2018, closing a stake of 5,315 shares — an estimated $206K sold.

Northstar Wealth Partners first reported a position in HRTX in Q2 2018 and held it in 1 quarter. The position peaked at $206K in Q2 2018. 194 funds tracked by Wall St. Rank hold HRTX as of Q3 2018.

  • Northstar Wealth Partners reported no remaining Heron Therapeutics position as of Q3 2018 after selling out during the quarter.
  • Northstar Wealth Partners sold 5,315 Heron Therapeutics shares in Q3 2018, an estimated $206K.
  • Northstar Wealth Partners first reported a position in Heron Therapeutics in Q2 2018 and held it in 1 quarter.
  • Northstar Wealth Partners's Heron Therapeutics position peaked at $206K in Q2 2018.
  • 194 funds tracked by Wall St. Rank held Heron Therapeutics as of Q3 2018.

Based on Northstar Wealth Partners's 13F filing for Q3 2018, filed 14 Nov 2018.